36 Participants NeededMy employer runs this trial
ARO-RAGE for Asthma
MM
Overseen ByMedical Monitor
Age: 18+
Sex: Any
Trial Phase: Phase 2
Sponsor: Arrowhead Pharmaceuticals
Prior Safety DataThis treatment has passed at least one previous human trial
What You Need to Know Before You Apply
What is the purpose of this trial?
The purpose of this study is to evaluate the impact of inhaled ARO-RAGE on the late asthmatic response (LAR) following an inhaled allergen challenge in participants with mild atopic asthma.
Are You a Good Fit for This Trial?
Inclusion Criteria
Established allergy confirmed by positive skin prick test at screening
My mild asthma is stable and my lung function is at least 70% of normal.
Willing and able to perform lung function tests and other study-related procedures
See 1 more
Exclusion Criteria
I have another serious lung disease besides asthma.
I have a condition that makes methacholine testing unsafe for me.
I regularly use medications that affect my asthma or immune system.
What Are the Treatments Tested in This Trial?
Interventions
- ARO-RAGE
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Placebo Group
Group I: ARO-RAGEExperimental Treatment1 Intervention
ARO-RAGE inhalation
Group II: PlaceboPlacebo Group1 Intervention
Normal saline (0.9%)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Arrowhead Pharmaceuticals
Lead Sponsor
Trials
45
Recruited
6,200+
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.